Viridian Therapeutics

VRDN

19.9000.10% ( +0.020 )

Closed: Jul 30, 15:59:57 (EDT)

Q1 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Preview: Viridian Therapeutics(VRDN) predict that the Revenue is 141 K (+95.83%), Beat estimate;the EBIT is -116.17 M (-23.76%), Beat estimate;the EPS is -0.9 (-3.45%), Beat estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueExceed expectations

0.00B95.83%

0.00B61.46%

+0.00B157.29%

EBITExceed expectations

-0.12B23.76%

-0.12B29.56%

+0.01B5.80%

EPSExceed expectations

-0.93.45%

-1.088925.16%

+0.188921.71%

Revenue

ActualEstimateUnit: USD

EBIT

ActualEstimateUnit: USD

Net income

ActualEstimateUnit: USD

EPS

ActualEstimateUnit: USD